Amero Joins CSR
Dr. Sally A. Amero
recently joined the Center for Scientific Review
as a scientific review administrator in the genetic sciences initial
review group. Her expertise is in molecular genetics — especially
recombinant DNA technology and gene cloning — protein synthesis,
chromosomes, transcription, RNA processing, human genetics and
human gene therapy. At CSR, she will manage review of grant
applications for the Small Business Innovation Research and
Technology Transfer programs. Amero received her Ph.D. in
genetics and developmental biology from West Virginia University.
Prior to joining CSR, she held appointments at the University of
Virginia, Washington University in St. Louis, and Loyola University,
Chicago.
Tompkins New NIGMS Program Director
Neurogeneticist Dr. Laurie Tompkins
has joined NIGMS as a
program director in the Division of Genetics and Developmental
Biology, where she will manage a portfolio of grants covering the
area of transcriptional regulatory proteins. She comes to NIGMS
from Temple University, where she has been a professor of biology
since 1992. She began her studies on the sexual behavior of fruit
flies in 1977, when she joined Dr. Jeffrey Hall's laboratory at
Brandeis University as a postdoctoral fellow. In 1981, she became a
faculty member at Temple. During that time, she also served on the
faculty at Woods Hole Marine Biology Laboratory, where she
participated in a course on neural systems and behavior from 1985
to 1988.
White Heads New NCI Office
Dr. Jeffery D. White
has been named director of NCI's new Office
of Complementary and Alternative Medicine. A graduate of Cornell
University and Howard University College of Medicine, he trained
in internal medicine, oncology and hematology at Washington
Hospital Center. From 1990 to 1993, he was a clinical associate in
the Metabolism Branch, NCI, and subsequently served there as a
staff fellow. For the past year, he has been director of the Clinical
Trials Program in the Metabolism Branch. White has been interested
in alternative and complementary approaches to therapy and has
served as an oncology consultant to the NIH Office of Alternative
Medicine. He will be NCI's liaison to OAM's successor, the new
National Center for Complementary and Alternative Medicine.
Up to Top